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Despite numerous studies in the past it is not possible yet to predict postoperative liver failure
and safe limits for hepatectomy. In this study the following liver function tests ICG-ER
(indocyaninegreen elimination rate), GEC (galactose elimination capacity) and MEGX-F
(monoethylglycinexylidid formation) are examined with regard to loss of liver tissue and
prediction of operative risk. Liver function tests were assessed in 20 patients prior to liver
resection and on the 10th. postoperative day. Liver and tumor volume were measured by
ultrasound and pathologic specimen and the parenchymal resection rate was calculated. In
patients without cirrhosis (n 10) ICG-ER and MEGX-F remained unchanged after
resection, GEC was reduced but did not correspond to the resection rate. Patients with
cirrhosis (n 10) had a significantly lower ICG-ER and GEC before resection than patients
without cirrhosis. After resection these tests were unchanged. Patients with liver related
complications and cirrhosis (n 5) had lower ICG-ER and GEC than patients with cirrhosis
and no complications. In the postoperative course all liver function tests in these patients were
significantly lower compared to preoperative results. Comparing liver function tests ICG
serves best to indicate postoperative liver failure. Liver function tests do not correspond with
loss of liver tissue.
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INTRODUCTION
Liver resection is the only method to cure primary and
metastatic liver tumors. Standardization ofthe opera-
tion has led to a decrease in operative mortality, but
the mortality rate is still near 20%. In approximately
70% HCC is combined with cirrhosis (Table 1). These
persons bear a high risk of developing liver insuffi-
ciency, since liver function and liver regeneration is
impaired6,9. Despite numerous studies in the past it is
not yet possible to predict postoperative liver failure
and safe limits for hepatectomy. Some authors prefer
the determination ofprotein synthesis like coagulation
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analysis or urea-nitrogen-synthesis-rate to estimate
preoperative liver function in cirrhotic patients but a
common standard does not exist yet. Quantitative
liver function tests are well known in hepatology but
since the test procedure is elaborate and therapeutic
consequences are lacking their use is limited to special
questions. Progress in surgery and transplantation
induced a reestimation of these tests3,4,1.
The tests commonly used now and employed in our
study are the ICG, GEC and MEGX tests.
ICG is a dye which is excreted by the liver depen-
dant on liver blood flow. The elimination rate normal-
ly amounts 16-20%/minll. Galactose is converted to
galactose-l-phosphate by the enzyme galactokinase.
The elimination capacity should reflect the metaboli-
cally active liver tissue. The normal value is about 6,
5 mg/min kg12. MEGX is a metabolite of lidocaine.
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Table 1 Review of the literature (reference)
HCC Cirrhosis Mortality
Rate
Okamoto 19841 38 78% 26%
Nagorny 19892 110 24% 9%
Takenaka 19903 191 66% 12,6%
Tsuzuki 19904 119 67% 15,1%
Choi 19905 174 67% 13,2%
Bismuth 19866 35 100% 14%
Franco 19907 72 100% 6,9%
Paquet 19918 23 100% 13%
The MEGX--formation is controlled by the cyto-
chrome P 450 system in the liver and is supposed to
indicate the active liver tissue as well1.
In our study we raised the following issues:
1. Are the tests capable of recognizing a loss of liver
tissue by hepatectomy since they are called "quan-
titative"?
2. Can they discreminate cirrhotic from unaffected
livers?
3. Can we predict the operative risk of hepatectomy
with the help of liver function tests?
Methods
In 34 patients undergoing surgery for hepatectomy,
cholecystectomy or hydatid cyst resection liver func-
tion tests were assessed prior to operation and on the
10th. postoperative day. Liver volume and tumor
volume were determined by ultrasound at the same
time in order to calculate the parenchymal resection
rate described by Okamoto 1. The resected liver speci-
men served as a control for the calculation of the
volume resected. The incidence of cirrhosis was
documented. The postoperative course was recorded
with special referrence to signs of liver insufficiency
like intractable ascites, coma or deficiant protein
synthesis.
Liver resection was performed in 20 patients, 6 of
them suffered from HCC. 10 Patients had liver cir-
rhosis proven by histological examination. Patients
Table 2 Study design
34 Patients
Preoperative
Operation
10th. Day
Postoperative
Liver function test
Evaluation oflivervolume and tumorvolume
Determination ofresection volume
Liver function test
Evaluation of residual volume
Hospital morbidity and mortality
Table 3 Patients
Operation n Indication n Cirrhosis
Liver resection 20 HCC 6 6
Metastasis 14 4
Pericystectomy 7 Hydatid cysts 7 0
Cholecystectomy 7 Cholelithiasis 7
with gall stone disease and hydatid cysts served as a
control group to show the effect of anaesthesia and
operation trauma on liver function. Informed consent
was obtained from each patient.
Liver Function Tests
The ICG test was performed by the bolus injection
technique described by Paumgartner1. The extinction
of the dye was measured in 7 serum samples, 3 to 21
min after injection of 0,5 mg/kg ICG. The elimination
rate was calculated by least square log linear-regres-
sion analysis ofthe descending portion oflCG extinc-
tion as a function of time.
The GEC-test was determined from serum samples
drawn 0, 20, 25, 30, 35, 40, 45, 50 and urine sample
120 min after iv. injection of 0,5 g/kg galactose. The
elimination capacity was calculated as proposed by
Tygstrup1.
The MEGX serum concentration was measured
15 min after iv. injection of 0,5 mg/kg lidoeaine by
fluoro polarization immuno assay (Abbott Laborato-
ries, Chicago) speeifi’ed by Oellerieh1.
Liver and tumor volume was determined pre- and
postoperatively by ultrasound1. The parenehymal re-
section rate was calculated according to the method by
Okamoto 1.
Supposing a normal distribution of the test values
the student-t-test was applied to calculate the signi-
ficance from mean values and standard deviation.
RESULTS
No operative death occurred in 20 cases of liver resec-
tion but there were 5 late complications and 3 patients
died because of liver failure. The majority of these
complications was induced by preexisting liver cirrho-
sis. It seems that the extent of resection is not only
necessarily a cause of liver failure. This may focus our
interest to the question whether the degree ofcirrhosis
and consequently the risk of postoperative liver
insufficiency can be determined prior to operation.
Therefore we allocated our patients to 3 categories:LIVER FUNCTION TESTS 15
Table 4 Hospital morbidity
Pat. Indication Cirrhosis Resection Compli-
No. rate cation
Death
HCC Yes 54% Coma 26th. day
8 Metastases No 40% Ascites No
20 HCC Yes 5% Coma 48th. day
24 HCC Yes 41% Coma 63th. day
25 HCC Yes 18% Ascites No
Resections with unaffected livers; resections in
patients with cirrhosis and uneventful postoperative
course; resections in patients with cirrhosis and liver
failure.
The results are shown separately for each test em-
ployed. (Fig. 1) The ICG-elimination rate apparently
is not influenced by liver resection in normal livers and
cirrhotic livers. Postoperative complications lead to a
significant decrease of the elimination rate (p 0,004
vs. preop in the same group). The difference between
the preoperative values of noncirrhotic and cirrhotic
livers is significant (p 0,001). There is a further drop
in the preoperative elimination rate of patients who
will develop liver failure but this is not significant.
The galactose elimination capacity (Fig. 2) shows a
significant decrease after resection in normal livers
(p 0,003). The regression equation however fails to
show a correlation between the resection rate and the
decrease of the elimination capacity (r 0,452174).
The difference between cirrhotic and non cirrhotic
livers is significant (p 0,001). Similar to the ICG
elimination there is a further decrease of GEC in
patients with liver failure. It cannot be explained why
GEC remains unchanged after resection in cirrhotic
patients. Postoperative complications result in a signi-
ficant decrease of the GEC (p 0,036 vs. preop).
Regarding the MEGX test (Fig. 3) we find a post-
operative rise mainly in the control group and with
decreasing extent in the resection groups. Only persons
with complicated postoperative course have a lower
MEGX value 15 min after lidocaine injection.
DISCUSSION
Generally the operative risk in liver surgery is esti-
mated on the basis ofserum chemical liver profile and
coagulation studies. Under the compensatory condi-
tion of the diseased liver these data are usually within
or near normal limits. Therefore it is difficult to predict
liver function following hepatectomy preoperatively.
In consequence it is desirable to apply a test which is
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Figure 2 Galactose elimination capacity before and after cholecystectomy, liver resection in unaffected livers and cirrhotic livers. Patients
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Patients with cirrhosis are allocated to a group with uneventful postoperative course or to a group with liver failure.LIVER FUNCTION TESTS 17
capable of determining liver function and to estimate
the limit of safe hepatectomy in those patients. Quan-
titative liver function tests are supposed to indicate the
metabolically active liver volume and liver function.
Several studies affirmed this statement. ICG is reduced
after functional hepatectomy in dogs and induction of
cirrhosis 14. A positive correlation between liver volume
and GEC has been found in aging man 15. In our study
onlyGEC indicates loss of liver tissue but the decrease
of test level does not correlate with the resection rate.
It has been shown that liver resection induces an addi-
tional capacity for metabolizing galactose16. This may
serve as an explanation for our results, that liver
resection is not followed by an adequate reduction of
elimination capacity.
The ICG elimination rate performed by the bolus
injection technique reflects the liver perfusion
1 and
depends on intrahepatic shunting to be found in cir-
rhotic and tumor bearing livers 17. Therefore it is not a
valuable parameter of the active liver volume. As we
know other application techniques are apt to show a
volume dependant ICG elimination8 but application
form and calculation are complicated and not suitable
for clinical use. The MEGX formation interferes with
many drugs
9 and maintains a wide interindividual
range of test values. In our opinion the test procedure
which consists of only one blood sample after 15, 30
or 60 minutes, is not sufficient for analyzing liver
function.
The value of the ICG test, GEC and MEGX test in
indicating presence of cirrhosis is not doubted,2,21.
Since we are aware of liver cirrhosis by routine histo-
logical examination done preoperatively the superi-
ority ofthe tests to simple methods like determination
of the Child index is questioned22,23. The results of our
examination present a significant difference between
test values ofcirrhotic and non cirrhotic livers only for
ICG and GEC. In contrast to ICG and GEC the
MEGX test fails to recognize cirrhotic livers.
The ICG elimination is diminished postoperatively
in patients suffering from liver related complications24.
This statement is confirmed by our results. Further
information is awaited to select patients with impend-
ing liver insufficiency by preoperative investigations to
enhance the effect of liver function tests. Okamoto,
Mizumoto8 and Yamanaka5 have developed sophis-
ticated score systems including ICG which are able to
recognize high risk patients. Yet clinical application is
not widely accepted. Although patients with cirrhosis
and postoperative complications have lower ICG and
GEC values in our study than patients with cirrhosis
and uneventful postoperative course this difference is
not significant presumably due to the small number of
patients.
As the test procedure for determination ofGEC is
complicated and time consuming the ICG test in our
opinion serves best to distinguish high risk patients.
The score system proposed by Yamanaka2s, which
includes the ICG elimination, is more accurate than
the ICG test but it is difficult to perform in daily
clinical routine.
Although quantitative liver function tests examined
in our study do not correspond to the actual liver
volume, they seem to be a valuable parameter to select
patients with severe cirrhosis who are likely to suffer
from postoperative liver insufficiency. Those patients
should be treated by a limited resection.
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